Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126675281 | 12667528 | 1 | I | 20160719 | 20160809 | 20160819 | 20160819 | EXP | GB-MHRA-TPP10309973C2212500YC1468942410479 | GB-TEVA-684502ACC | TEVA | 70.00 | YR | F | Y | 51.00000 | KG | 20160819 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126675281 | 12667528 | 1 | PS | TRIMETHOPRIM. | TRIMETHOPRIM | 1 | U | U | 18679 | ||||||||||
| 126675281 | 12667528 | 2 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | 1 DOSAGE FORMS DAILY; | 1 | DF | 0 | 1 | DF | QD | ||||||
| 126675281 | 12667528 | 3 | C | SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S)) | HYPROMELLOSE 2910 (4000 MPA.S) | 1 | USE AS DIRECTED | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126675281 | 12667528 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126675281 | 12667528 | Mouth ulceration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126675281 | 12667528 | 1 | 20160719 | 0 | ||
| 126675281 | 12667528 | 2 | 20160719 | 0 | ||
| 126675281 | 12667528 | 3 | 20160113 | 0 |